The Private Securities Litigation Reform Act of 1995 provides a safe harbor from civil litigation for forward-looking statements accompanied by meaningful cautionary statements. Except for historical ...

Please provide your email address to receive an email when new articles are posted on . GenePOC Inc. has announced the launch and FDA clearance of its Clostridium difficile molecular test, GenePOC ...

Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...

SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...

Great Basin Corp. has announced it has received FDA 510(k) clearance for its molecular diagnostic test for Clostridium difficile, according to a news release (pdf). “Workflow matters, especially when ...

MedCity News’ Brandon Glenn breaks down the recent FDA approval of Meridian Bioscience’s pediatric version of its C. difficile test on this week’s edition of Health Journal on ONN. Meridian said its ...

Empirical intravenous vancomycin, piperacillin–tazobactam, and metronidazole were administered owing to concern about polymicrobial sepsis. Over the next hour, the patient became increasingly ...

CINCINNATI, Ohio — Meridian Bioscience Inc. reported record revenue and net income for its fiscal first quarter, despite increased competition for sales of C. difficile test kits. The Cincinnati ...

Please provide your email address to receive an email when new articles are posted on . Lewis and colleagues tested the three EHR-based interventions at three hospitals. The first intervention, ...

This study explores the effectiveness of toxin testing in predicting Clostridioides difficile infection (CDI) outcomes, revealing that patients with negative toxin results were less likely to ...

CHELMSFORD, Mass., July 20, 2021 /PRNewswire/ -- First Light Diagnostics is developing and commercializing breakthrough automated diagnostic products for rapidly detecting infections and determining ...

A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...